e-Compared-S: Comparative Effectiveness Research on Internet-based Depression Treatment - Spanish Trial

NCT02361684 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 160

Last updated 2019-09-20

No results posted yet for this study

Summary

To compare the clinical and cost-effectiveness of blended Cognitive Behavioural Therapy (CBT) for adults with major depressive disorder (MDD) with treatment as usual (TAU) in Spanish population.

Conditions

Interventions

BEHAVIORAL

Blended CBT treatment

Internet based blended CBT depression treatment combines individual face-to-face cognitive behavioural therapy (CBT) with CBT delivered through an Internet based treatment platform with mobile phone components (either integrated in the treatment platform or as a separate system). The core components of the CBT treatment are: (1) psycho-education, (2) cognitive restructuring, (3) behavioural activation, (4) positive psychology, and (5) relapse prevention. These will be delivered over 10 sessions. For this study, the ratio between the number of face-to-face sessions and the number of online module will be 1/3 face-to-face and 2/3 online.

OTHER

Treatment as usual

Treatment as usual (TAU) is defined as the routine care that subjects receive when they are diagnosed with depression in the primary care system. In practice, this means that treatment as usual may vary between patients. We will not interfere with treatment as usual but we will monitor carefully which health care services are utilized by usual care patients using patient records and through self-report

Sponsors & Collaborators

  • University of Valencia

    collaborator OTHER
  • Universitat Jaume I

    lead OTHER

Principal Investigators

  • Cristina Botella Arbona, PhD · Universitat Jaume I;CIBERObn ISC III, Castellón de la Plana, Spain

  • Rosa Baños Rivera, PhD · Universitat de Valencia; CIBERObn ISC III, Castellón de la Plana, Spain

  • Azucena García-Palacios, PhD · Universitat Jaume I;CIBERObn ISC III, Castellón de la Plana, Spain

  • Ernestina Etchemendy, PhD · CIBERObn ISC III, Castellón de la Plana, Spain

  • Rocio Herrero Camarano, PhD · Universitat Jaume I

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-02-28
Primary Completion
2019-06-30
Completion
2019-09-30

Countries

  • Spain

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02361684 on ClinicalTrials.gov